Pridus Global Pharma Private Limited
About Pridus Global Pharma Private Limited
Data last updated:
Pridus Global Pharma Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 September 2022.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24299KA2022PTC166363.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Usha Choudhary and Ishwar Chouhdary.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at B1 – 502 Mahendra Arena Apartment Ananth Nagar Kammasandra Ecity Phase 2, Bangalore, Karnataka, India – 560100.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.56 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹73,460 (net margin -0.5%) and EBITDA of -₹37,460 (EBITDA margin -0.2%).
The company is associated with 1 brand: Pridus Global Pharma.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressB1 – 502 Mahendra Arena Apartment Ananth Nagar Kammasandra Ecity Phase 2, Bangalore, Karnataka, India – 560100
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Pridus Global Pharma Private Limited
The main business activity of Pridus Global Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Pridus Global Pharma Private Limited FY 2024 filings available
Pridus Global Pharma Private Limited reported revenue of ₹1.56 Cr (up 420% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Pridus Global Pharma Private Limited
Revenue rose 420% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Pridus Global Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | -₹37,460 | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | -₹73,460 | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Pridus Global Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -0.2% | •••• |
| Net Profit Margin | -0.5% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Pridus Global Pharma are in the company report.
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Pridus Global Pharma Private Limited
Pridus Global Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Samrat Multiservices Private Limited | ₹1.56 Cr (FY 2024) | •••• | •••• | 148.0% | •••• | Gorakhpur, Uttar Pradesh, India |
| Osl Scandinavian Private Limited | ₹1.56 Cr (FY 2025) | •••• | •••• | •••• | Cuttack, Odisha, India | |
| Comp Advertising Private Limited | ₹1.56 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | New Delhi, Delhi, India |
| Makhanamithila Producer Company Limited | ₹1.56 Cr (FY 2025) | •••• | •••• | 40.0% | •••• | Darbhanga, Bihar, India |
| Mohan Distributors Private Limited | ₹1.56 Cr (FY 2025) | •••• | •••• | -40.0% | •••• | Kolkata, West Bengal, India |
| Pridus Global Pharma Private Limited this company | ₹1.56 Cr (FY 2024) | •••• | •••• | 420.0% | •••• | Bangalore, Karnataka, India |
| Helles Management Consultants Private Limited | ₹1.56 Cr (FY 2024) | •••• | •••• | -28.0% | •••• | Kolkata, West Bengal, India |
| Teegee Super Stores Pvt Ltd | ₹1.56 Cr (FY 2024) | •••• | •••• | -23.0% | •••• | Jaipur, Rajasthan, India |
| Thenali Engineers and Contractors Private Limited | ₹1.56 Cr (FY 2023) | •••• | •••• | 67.0% | •••• | Ernakulam, Kerala, India |
| Asneel Industries Limited | ₹1.56 Cr (FY 2024) | •••• | •••• | -70.0% | •••• | Delhi, India |
| Precision Electro-Instumentation India Pvt Ltd | ₹1.56 Cr (FY 2024) | •••• | •••• | 8.0% | •••• | Kolkata, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Pridus Global Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Pridus Global Pharma Private Limited
Pridus Global Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Usha Choudhary | Director | 22 Sep 2022 | 4 Years 0 Months | Current |
| Ishwar Chouhdary | Director | 13 Mar 2023 | 3 Years 6 Months | Current |
Charges & Borrowings of Pridus Global Pharma Private Limited
Pridus Global Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Associated Brands with Pridus Global Pharma Private Limited
Pridus Global Pharma operates one associated brand: Pridus Global Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers products for life science research, cell culture, diagnostics, and drug discovery. | pridusglobalpharma.com |
Employees and EPFO Compliance at Pridus Global Pharma Private Limited
Employment history and EPFO contributions of people linked to Pridus Global Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Pridus Global Pharma Private Limited
Pridus Global Pharma Private Limited has 4 board changes on record since 2022: 2 appointments and 2 cessations. The latest: Ishwar Chouhdary ceased to be Additional Director on 30 Dec 2023.
Credit Ratings, Litigation & Regulatory Alerts for Pridus Global Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Pridus Global Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Pridus Global Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Pridus Global Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Pridus Global Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pridus Global Pharma Private Limited
Pridus Global Pharma is an active private limited company based in Bangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 September 2022 (4+ years old) and is registered under CIN U24299KA2022PTC166363.
Pridus Global Pharma reported revenue of ₹1.56 Cr for FY 2024 (up 420% YoY).
Pridus Global Pharma has 2 current directors:
- Usha Choudhary - Director
- Ishwar Chouhdary - Director
Pridus Global Pharma reported a net loss of ₹73,460 (net margin -0.5%) and EBITDA of -₹37,460 (EBITDA margin -0.2%) for FY 2024, as per its filed financial statements.
The CIN (Corporate Identification Number) of Pridus Global Pharma is U24299KA2022PTC166363. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pridus Global Pharma was incorporated on 22 September 2022, making it 4+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Pridus Global Pharma by revenue are Samrat Multiservices Private Limited, Osl Scandinavian Private Limited, Comp Advertising Private Limited, Makhanamithila Producer Company Limited, Mohan Distributors Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Ishwar Chouhdary ceased to be Additional Director on 30 Dec 2023. Rohit Choudhary ceased to be Director on 16 Mar 2023. Ishwar Chouhdary was appointed as Director on 13 Mar 2023. Pridus Global Pharma has 4 board changes on record in total.
The registered office of Pridus Global Pharma is at B1 – 502 Mahendra Arena Apartment Ananth Nagar Kammasandra Ecity Phase 2, Bangalore, Karnataka, India – 560100.
Pridus Global Pharma has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
Pridus Global Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.